Internationaal / International
Brazilië / Brasil
Canada / Canada
Latijns-Amerika / Latinoamérica
Verenigde Staten / USA
Oostenrijk / Österreich
Bosnië en Herzegovina / Босна и Херцеговина
Bulgarije / България
Kroatië / Hrvatska
Tsjechië & Slowakije / Česká republika & Slovensko
Frankrijk / France
Duitsland / Deutschland
Griekenland / ΕΛΛΑΔΑ
Hongarije / Hungary
Italië / Italia
Noords / Nordic
Polen / Polska
Portugal / Portugal
Roemenië & Moldavië / România & Moldova
Slovenië / Slovenija
Servië & Montenegro / Србија и Црна Гора
Spanje / España
Zwitserland / Schweiz
Turkije / Türkiye
Verenigd Koninkrijk & Ierland / UK & Ireland
China / 中国
India / भारत गणराज्य
Pakistan / Pākistān
Vietnam / Việt Nam
ASEAN / ASEAN
Israël / מְדִינַת יִשְׂרָאֵל
Algerije, Marokko en Tunesië / الجزائر والمغرب وتونس
Midden-Oosten / Middle East
:sharpen(level=0):output(format=webp)/up/dt/2025/10/WEB-OralB.jpg "Oral-B webinar: Lachen zonder gaatjes begint hier!")
:sharpen(level=0):output(format=webp)/up/dt/2025/10/WEB-Prikpunt.jpg "In 2024 meer meldingen bij PrikPunt")
:sharpen(level=0):output(format=webp)/up/dt/2025/10/WEB-Col-1.jpg "Column Reinier van de Vrie: Enquêtemoeheid")
:sharpen(level=0):output(format=webp)/up/dt/2025/10/WEB-Camp.jpg "Campagne ‘Oral health throughout life’")
:sharpen(level=0):output(format=webp)/up/dt/2025/10/WEB-Logo-preventieprijs.jpg "Ding mee naar de Backer Dirks PreventiePrijs2026!"){kind=logo}
:sharpen(level=0):output(format=webp)/up/dt/2025/07/3dprinting.jpg "3D printing")
:sharpen(level=0):output(format=webp)/up/dt/2025/07/aligners.jpg "aligners")
:sharpen(level=0):output(format=webp)/up/dt/2022/05/osstem_logo.png "Osstem Implant"){kind=logo}
:sharpen(level=0):output(format=webp)/up/dt/2014/02/3shape.png "3Shape")
:sharpen(level=0):output(format=webp)/up/dt/2025/05/UnionTech_LOGO.png "UnionTech"){kind=logo}
:sharpen(level=0):output(format=webp)/up/dt/2022/01/HASSBIO_Logo_horizontal.png "HASS Bio"){kind=logo}
:sharpen(level=0):output(format=webp)/up/dt/2022/01/Straumann_Logo_neu-.png "Straumann"){kind=logo}
:sharpen(level=0):output(format=webp)/up/dt/2024/01/ClearCorrect_Logo_Grey_01-2024.png "ClearCorrect"){kind=logo}
:sharpen(level=0):output(format=webp)/up/dt/e-papers/361823/1.jpg "DT Netherlands No. 6, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/360680/1.jpg "DT Netherlands No. 5, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/356741/1.jpg "DT Netherlands No. 4, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/355707/1.jpg "DT Netherlands No. 3, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/354125/1.jpg "DT Netherlands No. 2, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/352246/1.jpg "DT Netherlands No. 1, 2025")
E-papers
E-paper-edities zijn exacte digitale kopieën van de gedrukte publicaties van DTI. Lezers kunnen zoeken en navigeren door de e-paper, maar ook pagina's downloaden en afdrukken om offline te lezen. Om een brede verspreiding onder ons internationale lezerspubliek te bevorderen, is de toegang tot de meeste e-papers gratis.
:sharpen(level=0):output(format=webp)/up/dt/e-papers/286802/1.jpg "DT Italy No. 6, 2021")
DT Italy No. 6, 2021
Una corretta digitalizzazione dello studio parte da un cambiamento di visione strategica / Un progetto di aggregazione fra “neo-dentisti” e colleghi “anziani” / Resistenza agli antibiotici, grave minaccia per la salute pubblica globale / Attualità / News & Commenti / Cosmetic & Endo Tribune Italian Edition / Industry Report / Un recente studio conferma l’efficacia di CPC + CHX nella riduzione della carica virale del SARSCoV- 2 e ribadisce la ridotta attività antivirale della sola CHX / Notizie dalle Aziende / Formazione / Meeting & Congressi /
- Una corretta digitalizzazione dello studio parte da un cambiamento di visione strategica 1 - 5
- Un progetto di aggregazione fra “neo-dentisti” e colleghi “anziani” 1 - 6
- Resistenza agli antibiotici, grave minaccia per la salute pubblica globale 1 - 7
- Attualità 2 - 2
- News & Commenti 3 - 3
- Cosmetic & Endo Tribune Italian Edition 9 - 14
- Industry Report 15 - 15
- Un recente studio conferma l’efficacia di CPC + CHX nella riduzione della carica virale del SARSCoV- 2 e ribadisce la ridotta attività antivirale della sola CHX 16 - 17
- Notizie dalle Aziende 18 - 19
- Formazione 20 - 20
- Meeting & Congressi 21 - 23
:sharpen(level=0):output(format=webp)/up/dt/e-papers/360680/1.jpg "DT Netherlands No. 5, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/356741/1.jpg "DT Netherlands No. 4, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/355707/1.jpg "DT Netherlands No. 3, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/354125/1.jpg "DT Netherlands No. 2, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/352246/1.jpg "DT Netherlands No. 1, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/361823/1.jpg "DT Netherlands No. 6, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/361823/2.jpg "ISSUE")